COLM's 5.8% sales growth & 6.9% FCF margin limit upside. PRVA's negative returns signal value destruction. APLD's cash burn & dilution risk.
AVT's 11.3x P/E, flat sales & falling EPS signal caution despite 31% monthly gain.
EVTC's 15.8% revenue growth & 7.6x P/E shine; CLH & DOX show slower growth & higher valuations.
SMTC's margins shrink 16.5%, KBH EPS dips 13.4%, FTRE sales fall 2.9%. Avoid these.
TLRY's 215% 2018 gain is history. U.S. legalization remains distant, making it a risky bet.
MDB, EA, GEV boast strong cash, solid growth. MDB at 7.2x P/S, EA 16.6x EV/EBITDA, GEV 57.9x P/E.
ARM's 70% run-up may be too steep; TSM & ROKU offer value. Watch for pullbacks!
Sponsored
Must Read